Investigational Medication to Support Adults with Autism Spectrum Disorder

The Cortica Innovation Network is excited to announce a clinical for an investigational treatment to support socialization and emotional regulation for adults with Autism Spectrum Disorder. This medication uses a novel mechanism to affect serotonin levels – you may be eligible for this study if you are in California, have diagnoses (or suspected) ASD, and are seeking to strengthen your social skills through an investigational medication.

Inclusion criteria:

• 18-45 years old
• Diagnosed (or suspected) Autism Spectrum Disorder
• Seeking to strengthen social engagement skills
• Uses fluent spoken language

Has a designated study partner who is also willing to participate.

Exclusion criteria:
• Seizures requiring current medication management
• History of migraines
• Unable to swallow tablets
• Unstable medical or psychiatric illness
• Currently using certain medications for ASD – contact our study team to discuss

• Testing: ASD assessment, IQ assessment, psychiatric questionnaires, and medical evaluations
• Frequency of visits: 10 visits (every 2-3 weeks) over 4 months
• Costs: No costs will be charged for any of the study procedures.
• Payment: In return for the time, effort, and travel expenses, adults with their study partners will be compensated $200 per visit

As many of you know, ASD comes with a range of strengths and challenges, particularly in social interactions and communication. Currently, there are no FDA-approved treatments that specifically target these core features. Researchers have been exploring the role of serotonin, a key neurotransmitter, in ASD. Serotonin is crucial for regulating social behavior and emotional responses, and some research suggests that it may play a significant role in some of the differences seen in individuals with ASD.